345 Park Avenue South

Mega Menu WP The Core Labs Behind the Deals - Image

Blue

News & Insights

Your Home in NYC

Cure Founders Pass Membership Benefits 03 Tab Bar Image

Dark Blue

Apply for Membership

Where Healthcare Innovators Connect

Magenta

Attend An Event

Accelerating Advances in Health

Green

About

Contact us

## About 
Cathy Cassata is a freelance writer who covers health, mental health, medical news, and inspiring people.

## Experience
Cassata has more than 15 years of experiencing writing for a variety of publications and websites including Healthline, Health, Yahoo, and Verywell. She has interviewed hundreds of experts from a wide range of backgrounds, including physicians, psychologists, sociologists, researchers, and scientists. She also interviews celebrities, professional athletes, and everyday people about their personal health journeys. With an aptitude for listening to others, asking thought-provoking questions, and writing with empathy and accuracy, Cathy crafts stories worth reading. Read more about her and her work [here](https://www.cathycassatawrites.com) and view her writing portfolio [here](https://authory.com/CathyCassata). You can connect with her on [Facebook](https://www.facebook.com/cassatastyle/), [X](https://x.com/cassatastyle?s=11), [Instagram](https://www.instagram.com/cassatastylewrites/), and [LinkedIn](https://www.linkedin.com/in/cathy-cassata-healthwriter/).

## Education
Cassata holds a BA in English writing and a BA in political science from Dominican University in River Forest, Ill. She also obtained an editing certificate from the University of Chicago.

Contributing Writer

The race is shifting from how much to what kind of weight patients lose. These nine companies are building on what Ozempic started, betting on pills instead of injections, drugs that spare muscle, and uses well beyond obesity.

Biotech Companies Developing Next-Generation GLP-1 Drugs

9 Companies Developing Next-Generation GLP-1 Drugs

Searching for cures and therapies for rare diseases is no longer a niche market. Instead, it has become a major sector of biotech. Here are 11 companies that are leading the way.

Companies Advancing Treatments for Rare Diseases thumbnail

11 Companies Advancing Treatments for Rare Diseases

These Boston area conferences bring together leading scientists, entrepreneurs, industry executives, and investors to share the latest research, explore therapeutic discoveries, and shape the future of medicines and therapies.

12 Best Biotech Conferences in Boston in 2026 

New York City is where Wall Street meets the biotech pipeline, forging deals that will help define the next decade of medicine. These conferences will get you in on the action.

Biotech Conferences in New York City Image

8 Best Biotech Conferences in NYC in 2026

The dates, locations, costs, and what to expect from 13 major biopharma and life sciences events, from ASCO to J.P. Morgan.

13 Key Biopharma Conferences in 2026-2027

Multi-modal AI, computational pathology, and liquid biopsy are converging and these companies are turning the promise of AI diagnostics into clinical reality.

9 Biotech Companies Using AI to Reshape Diagnostics

The latest medtech venture capital news, updated weekly—tracking major funding rounds of $10M or more in 2026.

Cure’s Medtech Funding Tracker 2026

From RNA therapies to AI-enabled diagnostics, these companies are targeting one of medicine's biggest and most stubborn problems.

10 Biotech Companies Making Major Advances in Cardiovascular Disease

These companies are building procedure-driven devices with a clear path to FDA clearance and commercialization.

8 MedTech Startups to Watch in 2026

From ambient scribes to revenue cycle automation, these companies stand out for their solutions to healthcare's most persistent operational and clinical bottlenecks.

11 AI Companies Reshaping Healthcare Delivery and Clinical Workflows In 2026

Investment in women’s health is accelerating as founders build solutions that address longstanding gaps in care. These nine startups are developing technologies and care models that span fertility, maternal health, menopause, and healthy aging.

9 Women’s Health Startups to Watch in 2026 

Explore Seattle's most impactful biotech and life sciences companies, and learn why Washington continues to be one of the nation’s leading states for biopharma investment.

9 Biggest Biotech and Life Science Companies In Seattle

The Minneapolis-St. Paul region is experiencing a lot of growth in the biotech and life-sciences industry. Here are eight of the biggest biotech companies with connections to the area.

8 Biggest Biotech and Life Science Companies in Minneapolis and St. Paul

Salt Lake City’s biotech and life-sciences industry is experiencing a lot of growth. Here are eight of the biggest biotech companies with connections to the area.

7 Biggest Biotech Companies in Salt Lake City

As patients turn to AI for health answers, founders and healthcare builders are facing tough decisions around trust, regulation, escalation to human care, and how quickly to move.

ChatGPT Health Marks a Turning Point in Patient Expectations, Forcing Hard Choices for Innovators

From AI-driven drug discovery to next-generation diagnostics, these precision medicine startups are shaping how personalized care reaches patients in 2026.

9 Precision Medicine Startups to Watch in 2026

A list of the most promising anti-aging and longevity startups to watch in 2026, featuring companies developing epigenetic reprogramming, senolytics, AI-driven drug discovery, and next-generation cell rejuvenation therapies.

Anti-Agent2-hero

11 Anti-Aging and Longevity Startups to Watch in 2026

A tech-transfer leader from the University of Minnesota outlines six actionable tips to help you secure the right industry partner—from defining your needs to leveraging your network and TTO.

How to Find the Right Industry Partner for Your Research—Expert Tips That Actually Work

Janis Paradiso, Director of the Office of Biotechnology and Business Development at Albert Einstein College of Medicine, explains how her team supports researchers from pre-innovation to commercialization.

Tech Transfer for Biotech: How to Turn Your University Into Your First Backer

A look at AI tools that surface rare-disease patients from limited data—biomarker discovery, EHR scanning, and clinician assistants that aim to shorten the diagnostic delay.

AI Is Quietly Solving One of Biotech’s Hardest Problems: Rare Disease Detection

A biotech CFO shares what it actually takes to raise a Series B today, from proving clinical traction to securing a true lead investor and building a runway that can withstand delays. 

The Series B Playbook—How Biotech Founders Secure Their Next Big Round

Two biotech CEOs break down what it actually takes to raise a Series A, including how they sustained investor interest, built credibility through traction, and navigated a longer, diligence-heavy fundraising cycle.

Raising a Series A in Today’s Market—What Founders Need to Know

Two biotech CEOs break down what it actually takes to raise pre-seed capital, including how they built momentum, secured early believers, and converted traction into investment.

How to Raise Pre-Seed Funding, From Biotech Founders Who’ve Done It

Marissa Fayer, CEO of DeepLook Medical, and Oriana Papin-Zoghbi, Co-Founder and CEO of AOA Dx, share what they’ve learned while raising seed funding.

How to Nail Your Seed Raise—From Biotech CEOs Who’ve Been Through It

Based on company wind-downs across 2025, we've investigated the pressures threatening biotech and healthcare startups, including capital constraints and misaligned ROI timelines.

7 Threats to the Survival of Biotech Startups in 2025

Tech transfer experts from the University of Pennsylvania and Albert Einstein College of Medicine breakdown each pathway to commercialization. 

License, Spin Out, or Publish? How to Make the Translational Call

Collaborations fuel biotech and healthcare innovation, but unclear agreements can lead to costly IP disputes. Patent litigator Anthony J. Fitzpatrick of Duane Morris LLP explains how entrepreneurs can safeguard ownership, avoid accidental disclosures, and structure deals that protect long-term value.

How to Protect Your Healthcare IP When Collaborating

Intellectual property (IP) is often a startup’s most valuable asset. Patent litigator Anthony J. Fitzpatrick of Duane Morris LLP shares what healthcare entrepreneurs need to know about patents, trade secrets, and copyrights, plus common costly mistakes to avoid.

How Healthcare Entrepreneurs Can Protect Their Innovations: Patents

Richard Magid, PhD, Vice President of Technology Transfer at Colorado State University explains how university faculty and students can navigate IP, licensing, and partnerships to commercialize healthcare discoveries.

From Lab to Market: How Tech Transfer Turns Research into Real-World Impact image

How Tech Transfer Offices License Discoveries and Launch New Biotech Companies

Experts from Novastone Capital Advisors and CORE IR share how capitalization tables reveal startups' decision-making power, dilution risks, IP ownership, and exit potential.

Decoding Capitalization Tables: The Healthcare Founder’s Map of Ownership, Dilution, and Control

Funding experts reveal how healthcare entrepreneurs’ messaging can build trust, communicate value, and position your startup for long-term success.

What Not to Say to Investors: 5 Messaging Mistakes That Can Derail Your Pitch

Nell Smircina of Novastone Capital Advisors and Vivian Cervantes of CORE IR explain how founders should approach valuation and why getting it wrong can cost you more than funding.

What Every Healthcare Startup Needs to Know About Valuation

Nell Smircina of Novastone Capital Advisors and Vivian Cervantes of CORE IR explain how choosing the right mix of advisors can support your company’s mission and milestones.

Your Healthcare Startup Needs an Advisory Board—Here’s How to Build One That Matters

16-year-old entrepreneur Khartik Uppalapati, co-founder of the RareGen Youth Network, is combining AI innovation and advocacy to reshape how rare diseases are diagnosed and addressed globally.

How a Teen Turned His Rare Diagnoses into a Rare Movement

Ali Chappell, PhD, RD, Co-Founder and CEO of Lilli Health, shares how she transformed her experience with PCOS into a data-driven nutrition and wellness company offering services and app to have “a dietitian in your pocket.”


How a PCOS Diagnosis Fueled One Founder’s Mission to Disrupt Women’s Health

Robyn Riseberg, MD, shares how she founded Boston Community Pediatrics as the first nonprofit private pediatric practice to bring integrated healthcare to children in Boston.

Reimagining Pediatric Care: How One Nonprofit is Setting a New Standard for Health Equity

Oriana Papin-Zoghbi, Co-Founder and CEO of AOA Dx, created a blood test to detect ovarian cancer at early stages when women’s survival rate is higher.

Cure’s Biotech Funding Tracker 2026

Cure Original Report: The Core Labs Behind the Deals

Your Home in NYC

Where Healthcare Innovators Connect

Accelerating Advances in Health

Cathy Cassata

37 Articles by Cathy Cassata